Fundraising FoxHealthtech Startups
18,755 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
GeneCapture develops CAPTURE diagnostic technology that detects 200+ pathogens from a raw sample in about an hour and determines effective antimicrobial treatment within another 90 minutes, without a centralized lab, cold chain, or specialized technician. The point-of-care approach is aimed at infection detection in settings such as rural areas, schools, ships, airports, and battlefields.
0 investors
Geneius develops and commercializes autologous adoptive T-cell therapies designed to treat cancer by targeting the mutations driving a patient's disease. The company aims to deliver its immunotherapy through community oncologists at a lower cost than CAR-T, in the oncology/immunotherapy space.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Genesis Innovation Group provides comprehensive medical device development services from ideation through commercialization, serving early-stage entrepreneurs and innovators with strategic guidance, technical expertise, and industry relationships.
0 investors
0 investors
0 investors
GeneVentiv Therapeutics is a pre-clinical gene therapy company that identifies, in-licenses, and develops gene therapies for patients with rare and serious diseases. Its programs target hemophilias, including inhibitor patients, and both infantile- and late-onset forms of Pompe disease.
0 investors
Avalyn Pharma (formerly Genoa Pharmaceuticals) is a biopharma company developing inhaled therapies for idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Its lead asset is inhaled pirfenidone (Aerodone), a nebulized reformulation designed to deliver effective lung levels while reducing the side effects of oral dosing.
0 investors
0 investors
0 investors
Genprex is a clinical-stage gene therapy company developing treatments for cancer and diabetes, including approaches that reintroduce tumor suppressor genes and stabilize glucose levels. Its therapies have received multiple FDA Fast Track Designations and are being evaluated in clinical trials.
0 investors
GenrAb develops neuroprotective therapies derived from the human immune system to treat neurological diseases including ALS, Parkinson's, Alzheimer's, and Multiple Sclerosis. The company addresses unmet needs in neurodegeneration treatment by harnessing immunological pathways to prevent disease progression.
0 investors
0 investors
Georgia Dental Group operates dental clinics offering comprehensive oral health care, including cosmetic, emergency, periodontics, general, family, restorative, and implant dentistry for patients of all ages. It serves communities in Eastman, Fitzgerald, and LaGrange, Georgia across six locations.
0 investors
0 investors
0 investors